CA2168264A1 - Novel 1, 4-(diphenylalkyl)piperazine derivatives - Google Patents

Novel 1, 4-(diphenylalkyl)piperazine derivatives

Info

Publication number
CA2168264A1
CA2168264A1 CA002168264A CA2168264A CA2168264A1 CA 2168264 A1 CA2168264 A1 CA 2168264A1 CA 002168264 A CA002168264 A CA 002168264A CA 2168264 A CA2168264 A CA 2168264A CA 2168264 A1 CA2168264 A1 CA 2168264A1
Authority
CA
Canada
Prior art keywords
compound
compounds
salt
neural function
function disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002168264A
Other languages
English (en)
French (fr)
Inventor
Yoichi Kawashima
Junzo Matsumoto
Kiyoshi Matsuno
Toshihiko Senda
Keiko Hirano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2168264A1 publication Critical patent/CA2168264A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002168264A 1993-07-28 1994-07-25 Novel 1, 4-(diphenylalkyl)piperazine derivatives Abandoned CA2168264A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5/185839 1993-07-28
JP18583993 1993-07-28

Publications (1)

Publication Number Publication Date
CA2168264A1 true CA2168264A1 (en) 1995-02-09

Family

ID=16177784

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002168264A Abandoned CA2168264A1 (en) 1993-07-28 1994-07-25 Novel 1, 4-(diphenylalkyl)piperazine derivatives

Country Status (11)

Country Link
US (1) US5736546A (enExample)
EP (1) EP0711763B1 (enExample)
KR (1) KR100299734B1 (enExample)
CN (1) CN1042029C (enExample)
AT (1) ATE197047T1 (enExample)
CA (1) CA2168264A1 (enExample)
DE (1) DE69426157T2 (enExample)
ES (1) ES2151930T3 (enExample)
FI (1) FI960364A7 (enExample)
NO (1) NO960270D0 (enExample)
WO (1) WO1995004050A1 (enExample)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859295A (en) * 1994-12-05 1999-01-12 University Of Kentucky Research Foundation Canavanine analogs and their use as chemotherapeutic agents
US5889006A (en) * 1995-02-23 1999-03-30 Schering Corporation Muscarinic antagonists
IL117149A0 (en) * 1995-02-23 1996-06-18 Schering Corp Muscarinic antagonists
HUP9601331A3 (en) * 1996-05-17 2000-06-28 Egyt Gyogyszervegyeszeti Gyar Piperazine- and homopiperazine-derivatives, process for producing them and pharmaceutical compositions containing them
US5952349A (en) * 1996-07-10 1999-09-14 Schering Corporation Muscarinic antagonists for treating memory loss
ATE227708T1 (de) * 1996-07-10 2002-11-15 Schering Corp 1,4-disubstituierte piperdine als muskarin- antagonisten
US5860391A (en) * 1996-08-06 1999-01-19 First Brands Corporation Absorbents containing activated carbons
US6713651B1 (en) * 1999-06-07 2004-03-30 Theravance, Inc. β2-adrenergic receptor agonists
CN1131221C (zh) 1998-11-09 2003-12-17 参天制药株式会社 药物依赖症的治疗剂
WO2001000604A1 (fr) * 1999-06-30 2001-01-04 Santen Pharmaceutical Co., Ltd. Ligand de liaison avec le recepteur sigma-1 du cerveau
DE10050236A1 (de) * 2000-10-11 2002-04-25 Merck Patent Gmbh Verwendung bestimmter Substanzen, die an den Sigma-Rezeptor binden, zur Behandlung von Sarkomen und Karzinomen
CN1181065C (zh) 2002-05-08 2004-12-22 上海医药工业研究院 芳烷甲酰烷基哌嗪衍生物及其作为脑神经保护剂的应用
CN1172919C (zh) 2002-06-03 2004-10-27 上海医药工业研究院 芳烷醇哌嗪衍生物及其在制备抗抑郁症药物中的应用
EP1635805A4 (en) * 2003-06-12 2007-08-08 Ms Science Corp SIGMA RECEPTOR LIGANDS FOR NEURONAL REGENERATION AND FUNCTIONAL RE-ESTABLISHMENT
WO2005028457A1 (en) * 2003-09-23 2005-03-31 Fermion Oy Preparation of quetiapine
DE102004061593A1 (de) 2004-12-21 2006-06-22 Abbott Gmbh & Co. Kg Substituierte N-heterocyclische Verbindungen und ihre therapeutische Verwendung
US7985751B2 (en) * 2005-08-09 2011-07-26 M's Science Corporation Piperazine derivatives
WO2008096189A2 (en) * 2005-09-23 2008-08-14 M's Science Corporation Piperidine and piperazine derivatives
WO2007047978A2 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
EP2314289A1 (en) 2005-10-31 2011-04-27 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
CN101448503B (zh) * 2006-01-27 2011-04-13 株式会社爱慕知科学 哌啶和哌嗪衍生物
AU2007218086A1 (en) * 2006-02-15 2007-08-30 M's Science Corporation Piperazine derivatives
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2008060271A1 (en) * 2006-11-13 2008-05-22 M's Science Corporation Sigma ligands for neuronal regeneration and functional recovery
WO2009128057A2 (en) * 2008-04-18 2009-10-22 UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al Psycho-pharmaceuticals
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US8673920B2 (en) * 2009-05-06 2014-03-18 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2632465B1 (en) 2010-10-27 2015-12-30 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2012058134A1 (en) 2010-10-29 2012-05-03 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
ES2605164T3 (es) 2011-08-19 2017-03-13 Merck Sharp & Dohme Corp. Inhibidores del canal de potasio de la médula renal externa
WO2013039802A1 (en) 2011-09-16 2013-03-21 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2771005B1 (en) 2011-10-25 2016-05-18 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2771004B1 (en) 2011-10-25 2016-05-18 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9493474B2 (en) 2011-10-31 2016-11-15 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2773199B1 (en) 2011-10-31 2019-04-10 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9108947B2 (en) 2011-10-31 2015-08-18 Merck Sharp & Dohme Corp. Inhibitors of the Renal Outer Medullary Potassium channel
US9206199B2 (en) 2011-12-16 2015-12-08 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
AR092031A1 (es) 2012-07-26 2015-03-18 Merck Sharp & Dohme Inhibidores del canal de potasio medular externo renal
WO2014085210A1 (en) 2012-11-29 2014-06-05 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2014099633A2 (en) 2012-12-19 2014-06-26 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2956142B1 (en) 2013-02-18 2017-09-20 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9765074B2 (en) 2013-03-15 2017-09-19 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9751881B2 (en) 2013-07-31 2017-09-05 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9951052B2 (en) 2013-10-31 2018-04-24 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2016127358A1 (en) 2015-02-12 2016-08-18 Merck Sharp & Dohme Corp. Inhibitors of renal outer medullary potassium channel

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5583771A (en) * 1978-12-20 1980-06-24 Kanebo Ltd N-substituted trimethoxybenzylpiperazine derivative and its acid addition salt
JPS60155171A (ja) * 1983-12-10 1985-08-15 Wako Pure Chem Ind Ltd ポリメトキシベンジルピペラジン誘導体
JPS6133827A (ja) * 1984-07-27 1986-02-17 Mitsubishi Electric Corp 放電加工装置
JP2722250B2 (ja) * 1989-05-30 1998-03-04 興和株式会社 新規なジアミン化合物及びこれを含有する脳機能障害改善剤
CA2071897A1 (en) * 1989-12-28 1991-06-29 Richard A. Glennon Sigma receptor ligands and the use thereof
EP0566189A1 (en) * 1992-04-13 1993-10-20 Akzo N.V. Psychotropic piperazine derivative
US5428037A (en) * 1993-04-09 1995-06-27 Syntex Pharmaceuticals, Ltd. Heterocyclic derivatives in the treatment of Ischaemia and related diseases

Also Published As

Publication number Publication date
NO960270L (no) 1996-01-23
DE69426157T2 (de) 2001-05-17
FI960364A0 (fi) 1996-01-26
FI960364L (fi) 1996-01-26
DE69426157D1 (de) 2000-11-23
NO960270D0 (no) 1996-01-23
ATE197047T1 (de) 2000-11-15
EP0711763A4 (enExample) 1996-06-12
WO1995004050A1 (en) 1995-02-09
KR100299734B1 (ko) 2002-01-09
EP0711763A1 (en) 1996-05-15
EP0711763B1 (en) 2000-10-18
CN1042029C (zh) 1999-02-10
US5736546A (en) 1998-04-07
ES2151930T3 (es) 2001-01-16
CN1128026A (zh) 1996-07-31
FI960364A7 (fi) 1996-01-26

Similar Documents

Publication Publication Date Title
EP0711763B1 (en) 1,4-di(phenylalkyl)piperazine derivatives
US4070484A (en) Antiallergic composition containing aromatic carboxylic amide derivatives and method of using the same
KR100322415B1 (ko) 1-[(4-클로로페닐)페닐메틸]-4-[(4-메틸페닐)술포닐]피페라진의거울상이성체
US6080750A (en) Pyrimidine compound and anti-rotavirus composition
NO166557B (no) Innretning for omstabling av en bladstabel.
DE69508875T2 (de) Amidinophenol-Derivate als Protease-hemmende Verbindungen
US3706750A (en) Pyrrylaminoketone derivatives
NZ199215A (en) Secondary or tertiary omega-phenylalkylamines
JP2883970B2 (ja) 新規１，４−（ジフェニルアルキル）ピペラジン誘導体
KR101035931B1 (ko) 2-페닐벤조티아졸린 유도체로 이루어진 κ 오피오이드 수용체 작용약
CA2118425C (en) Benzothiazolesulfonamide derivative, method for preparing the same, and use thereof
US2830008A (en) Amines
US5317026A (en) Acetamide derivative and application thereof
US4703048A (en) Novel 1-benzhydryl-4-cinnamylpiperazine derivatives, and pharmaceutical compositions comprising said compounds as active ingredient for treating a cerebrovascular disease
ZA200308145B (en) Bicyclic guanidine derivatives and therapeutic uses thereof.
CA2050492C (en) Piperazine compounds, processes for preparation thereof and medical uses thereof
JP4567889B2 (ja) （（アミノイミノメチル）アミノ）アルカンカルボキシアミドおよび治療におけるその適用
US5036086A (en) Novel benzothiazole derivatives
DE69713128T2 (de) 4-(1-piperazinyl)benzosäurederivate, verfahren zu ihrer herstellung und ihre therapeutischen verwendungen
CA1276639C (en) Aminobenzamide derivatives
DeBernardis et al. Evaluation of the side arm of (naphthylvinyl) pyridinium inhibitors of choline acetyltransferase
US4034100A (en) Antihypertensive agents
US4978674A (en) Daimine derivatives, and method of manufacturing the same
US5294708A (en) Guanidine derivatives
JP2920727B2 (ja) 新規１，４−（ジフェニルアルキル）ホモピペラジン誘導体

Legal Events

Date Code Title Description
FZDE Discontinued